Signaturefd, LLC Pacific Biosciences Of California, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 4,627 shares of PACB stock, worth $9,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,627

Previous 1,757 163.35%

Holding current value

$9,022

Previous $2,000 250.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$1.2 - $2.17 $3,444 - $6,227	2,870 Added 163.35%	4,627 $7,000
Q2 2024 Jul 29, 2024	BUY	$1.36 - $3.65 $1,489 - $3,996	1,095 Added 165.41%	1,757 $2,000
Q1 2024 May 03, 2024	BUY	$3.52 - $9.59 $665 - $1,812	189 Added 39.96%	662 $2,000
Q4 2023 Jan 31, 2024	BUY	$5.97 - $10.36 $925 - $1,605	155 Added 48.74%	473 $4,000
Q1 2023 Apr 28, 2023	SELL	$7.94 - $12.02 $484 - $733	-61 Reduced 16.09%	318 $3,000
Q3 2022 Nov 08, 2022	BUY	$3.93 - $8.57 $326 - $711	83 Added 28.04%	379 $2,000
Q2 2022 Aug 10, 2022	SELL	$4.02 - $10.43 $892 - $2,315	-222 Reduced 42.86%	296 $1,000
Q1 2022 May 02, 2022	BUY	$8.43 - $20.9 $3,852 - $9,551	457 Added 749.18%	518 $5,000
Q4 2021 Jan 25, 2022	SELL	$19.26 - $30.08 $2,080 - $3,248	-108 Reduced 63.91%	61 $1,000
Q3 2021 Oct 28, 2021	BUY	$24.86 - $35.02 $4,201 - $5,918	169 New	169 $4,000
Q2 2021 Jul 26, 2021	SELL	$22.3 - $36.02 $379 - $612	-17 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$26.38 - $51.15 $448 - $869	17 New	17 $1,000
Q1 2020 Apr 23, 2020	SELL	$2.36 - $5.26 $582 - $1,299	-247 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$4.6 - $5.57 $1,136 - $1,375	247 New	247 $1,000

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account